Damage assessment in ANCA-associated vasculitis.

Journal article

Antineutrophil cytoplasm antibody associated vasculitis has been transformed from life-threatening conditions to chronic relapsing long-term diseases as a result of significant advances in immunosuppressive therapy. Although mortality still occurs, it is much less frequent, with an average 5-year survival of over 70 %. In the setting of chronic conditions, it becomes increasingly important to monitor the burden of disease in terms of both active inflammation requiring immunosuppression and ch...

Expand abstract

Authors: Bhamra, K; Luqmani, R

• Publication status: Published
• Journal: Current rheumatology reports
• Volume: 14
• Issue: 6
• Pages: 494-500
• Publication date: 2012-12-01
• DOI: 10.1007/s11926-012-0291-1
• EISSN: 1534-6307
• ISSN: 1523-3774
• Language: English
• Keywords: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Recurrence; Severity of Illness Index; Prognosis; Humans; Immunosuppressive Agents; Checklist